Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implementation and Evaluation of PIPAC for Peritoneal Carcinomatosis
NCT02320448Phase 2Completed
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin, oxaliplatin in peritoneal carcinomatosis (PC). Started Mar 2015; status: completed.
02
Drugs
cisplatindoxorubicinoxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT02320448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02320448.